Antibodies and Reagents for SARS-CoV-2 Research


In support of researchers uncovering mechanisms of the SARS-CoV-2 infection, we are continually developing new antibodies, kits, and reagents to help end the COVID-19 pandemic. This page will be updated regularly to provide the latest status for key targets. If you do not see your target of interest, please contact us directly.

For Research Use Only. Not For Use In Diagnostic Procedures.

Sign up to be the first to know about new SARS-CoV-2 product releases

Primary Antibodies

Target Products
SARS-CoV-2 Spike Protein SARS-CoV-2 Spike Protein (S1-NTD) (E7M5X) Mouse mAb #42172 New Antibodies in Development  
SARS-CoV-2 Nucleocapsid Protein New Antibodies in Development    
Human ACE2 ACE2 Antibody #4355 ACE2 (OTI1D6) Mouse mAb #15983 New Antibodies in Development


  • Custom Conjugation Services: save time and avoid the pitfalls of conjugating your own antibody, with validation, optimization, and testing by CST
  • Carrier Free Formulation: simplify assay development and ensure compatibility with your preferred platform by requesting your antibody without BSA
  • Proteomics Services: send your cellular samples for proteomics analysis to monitor viral protein modifications and host cell signaling response